<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02946827</url>
  </required_header>
  <id_info>
    <org_study_id>2016/464</org_study_id>
    <nct_id>NCT02946827</nct_id>
  </id_info>
  <brief_title>A Low FODMAPs Diet in Celiac Patients With Persistent Gastrointestinal Symptoms</brief_title>
  <official_title>The Efficacy of a Low FODMAPs (Fermentable Oligo- di- and Monosaccharides and Polyols) Diet in Celiac Patients With Persistent Gastrointestinal Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      FODMAPS (fructose, oligosaccharides, monosaccharides, disaccharides and polyols) are
      characterised as fermentable but poorly absorbed carbohydrates which enter the colon and are
      utilised by colonic bacteria. During fasting colonic nutrients are scarce but ingesting
      FODMAPS causes a rapid increase in carbohydrate which can overwhelm the microbiota's ability
      to utilise substrate. The excess reducing equivalents will generate hydrogen or methane. The
      principal symptoms are diarrhoea and abdominal distension. Patients with irritable bowel
      syndrome appear to benefit by restricting intake, possibly because they are hypersensitive to
      intestinal distension.

      The focus of the study is to evaluate if in celiac patients with persistent abdominal
      symptoms and with a correct gluten free diet, a low FODMAPs diet can improve their symptoms.
      Moreover the study would like to observe if a dietary restriction in FODMAPs carries the risk
      of nutritional inadequacy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of VAS (psychometric response scale level continuous line between two end-points 0-10) values of globel well-being in patients undergoing a balanced Gluten Free/low FODMAPs diet compared to patients in balanced gluten free diet.</measure>
    <time_frame>21 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement of VAS values of IBS symptoms in patients undergoing a balanced Gluten Free/low FODMAPs diet compared to patients undergoing only a balanced gluten free diet.</measure>
    <time_frame>21 days</time_frame>
    <description>Evaluated IBS symptoms are: abdominal pain, bloating, satisfaction with stool consistency, epigastric pain, postprandial fullness, early satiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of quality of life assessed through SF-36 questionnaire (eight scale scores) in patients undergoing a balanced Gluten Free/low FODMAPs diet compared to patients undergoing only a balanced gluten free diet.</measure>
    <time_frame>21 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of psychological problems and symptoms of psychopathology through the symptom checklist 90 R (SCL 90 R) in patients undergoing a balanced Gluten Free/low FODMAPs diet compared to patients undergoing only a balanced gluten free diet.</measure>
    <time_frame>21 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the dietary intake in micro and macro-nutrients before and after a Low FODMAP diet or a balanced Gluten Free diet through questionnaire.</measure>
    <time_frame>21 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Celiac Disease</condition>
  <arm_group>
    <arm_group_label>Low FODMAPs /balanced gluten free diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An expert in nutrition will give a balanced gluten free diet to patients, low in FODMAPs foods.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Balanced gluten free diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>An expert in nutrition will give a balanced gluten free diet to patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Balanced low FODMAPs /gluten free diet</intervention_name>
    <arm_group_label>Low FODMAPs /balanced gluten free diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Balanced gluten free diet</intervention_name>
    <arm_group_label>Balanced gluten free diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Celiac patients assessed through positive serology and histology

          -  functional patients according IBS Roma III criteria

          -  subjects with VAS&gt;5

        Exclusion Criteria:

          -  refractory celiac disease

          -  disaccharide intolerance (fructose an lactose breath test)

          -  abdominal surgery

          -  comorbidity

          -  patients recruited in other clinical trials

          -  positive patients at lactulose breath test (SIBO)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Leda Roncoroni, BS PhD</last_name>
    <phone>+39025503384</phone>
    <email>leda.roncoroni@unimi.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leda Roncoroni</last_name>
    <email>leda.roncoroni@unimi.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Milan</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luca Elli</last_name>
      <email>dottorlucaelli@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Luca Elli, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesca Ferretti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Federica Branchi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincenza Lombardo, BS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zaira Tuccitto, BS student</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2016</study_first_submitted>
  <study_first_submitted_qc>October 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2016</study_first_posted>
  <last_update_submitted>October 26, 2016</last_update_submitted>
  <last_update_submitted_qc>October 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Milan</investigator_affiliation>
    <investigator_full_name>Leda Roncoroni</investigator_full_name>
    <investigator_title>BS PhD</investigator_title>
  </responsible_party>
  <keyword>FODMAPs diet</keyword>
  <keyword>micro-macro nutrients intake</keyword>
  <keyword>IBS (Irritable Bowel Syndrome)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celiac Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

